Navigation Links
Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana

NEW CASTLE, Del., Feb. 27 /PRNewswire/ -- Arkion(R) Life Sciences has received a Section 18 Crisis Exemption to market Avipel(R) Corn Seed Treatment in Louisiana effective March 1, 2009. The EPA approval means that Louisiana farmers can use Avipel(R) to protect field and sweet corn from marauding blackbirds and grackles for the 2009 planting season. Formerly known as Avitec, Avipel(R) is applied to corn seed before planting and effectively stops birds from damaging crops by eating the newly planted seeds.

This is the first year Avipel(R) has received approval in Louisiana. The product is non-lethal to birds and has been shown to be highly effective in protecting corn seed from birds in over four years of use in states with particular bird problems such as Mississippi, Michigan, Minnesota, South Dakota and Wisconsin. Information about approved uses and labels may be found at the Arkion(R) Life Sciences web site:

According to Ken Ballinger (VP, Airepel(R)), Arkion(R) Life Sciences has been a pioneer in the development and commercialization of several formulations of bird repellent and bird management technologies. Arkion's patented formulations of anthraquinone have been effectively repelling geese with FlightControl(R) Plus and repelling birds from structures through the Airepel(R) Humane Bird Management business.

Arkion(R) Life Sciences LLC, based in New Castle, Delaware, is a technology-based company leading in the discovery, development and marketing of environmentally friendly, natural or nature identical bioactive compounds. The company has over 500 patents and patent applications worldwide around these technologies, including the area of feed preservation with N-Sure(R), and employs biotechnology to capitalize on new opportunities in the nutraceutical, pharmaceutical, animal health and agricultural markets. Arkion(R) has three major businesses: Airepel(R), supplying bird repellents which feature a non-lethal method to control where birds feed and roost; Hyperimmune eggs with markets in human and animal nutrition; and Bio-Technical Resources (Manitowoc, WI) which develops processes and products based upon fermentation technology such as glucosamine, N-acetylglucosamine and natamycin.

SOURCE Arkion Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Crisis Management PR Firms Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny
2. Countering an approaching water crisis
3. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
4. Life Science Labs Reacting to the Economic Crisis
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Pharmions Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
7. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
8. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
9. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
10. Odyssey Thera Granted U.S. Patent for Animal Imaging
11. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
Post Your Comments:
(Date:11/25/2015)... PUNE, India , November 26, 2015 /PRNewswire/ ... The Global Biobanking Market 2016 - 2020 ... biobanks by maintaining integrity and quality in long-term ... and enabling long-term cost-effectiveness. Automation minimizes manual errors ... improves the technical efficiency. Further, it plays a ...
(Date:11/25/2015)... , November 25, 2015 Studies ... and human plaque and pave the way for more effective ... in cats     --> ... commonly diagnosed health problems in cats, yet relatively little was ... Two collaborative studies have been conducted by researchers from the ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
Breaking Biology Technology:
(Date:11/19/2015)... -- Although some 350 companies are actively involved in molecular ... according to Kalorama Information. These include Roche Diagnostics, Hologic, Abbott ... of the 6.1 billion-dollar molecular testing market, according to ... Diagnostic s .    ... one company and only a handful of companies can ...
(Date:11/17/2015)... Paris , qui ... Paris , qui s,est tenu du ... leader de l,innovation biométrique, a inventé le premier scanner ... sur la même surface de balayage. Jusqu,ici, deux scanners ... les empreintes digitales. Désormais, un seul scanner est en ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):